Would you offer trastuzumab + pertuzumab alone for patients with early stage, HER2+ breast cancer for whom TCHP is clearly indicated but who adamantly refuse any cytotoxic therapy?  


Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at UCLA Jonsson Comprehensive Cancer Center
The patient who inspired my question has a 9.5cm t...
Medical Oncologist at University of Texas MD Anderson Cancer Center
The hard line might result in even more under-trea...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Presbyterian Healthcare Services
I think the point in the question was about avoidi...
Sign in or Register to read more